cchf vs 19.1 - prof. pedro perez
Published 4 years ago • 480 plays • Length 34:37Download video MP4
Download video MP3
Similar videos
-
30:12
cchf vs 16.1 - prof. ruben martin
-
35:07
cchf vs 20.3 - prof. kendall houk
-
25:03
cchf alumni virtual symposium part 1.4 - prof. elizabeth bess
-
1:41
dr. michael cheng | dana-farber cancer institute
-
1:25
esmo22: catherine marinac, phd | dana-farber cancer institute
-
4:16
esc tv 2015 - the vkorc1 promoter polymorphism is associated with elevated blood pressure
-
9:03
prognostic/predictive value of tumor-sidedness in crc
-
2:35
historical perspectives on the treatment of mrcc
-
1:09
dr. pal on developments in frontline treatments for patients with mrcc
-
5:36
webinar: deb ctace in primary and secondary liver cancer
-
2:37
esc tv 2014 - basic science
-
9:27
telazoparib vs physicians choice for patients with mbrca1 breast cancern
-
0:40
preview of covid-19 clinical forum 2021 – april edition | carlos del rio, md
-
59:54
july 16 2020 covid-19 international hpc webinar
-
2:29
association between severe iraes and pdcd1 polymorphism in mrcc
-
8:43
cso | escrs 2019 - erik mertens, md, febophth
-
1:38:33
[tctap 2023] live case & lecture #2: tavr
-
25:23
[ap valves & sh 2019] live case & lecture 2: tavr #4